Igs2em6(Nfatc1-cre/ERT2)Cya
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Igs2em6(Nfatc1-cre/ERT2)Cya |
| Name: |
intergenic site 2; endonuclease-mediated mutation 6, Cyagen Biosciences |
| MGI ID: |
MGI:8235601 |
| Synonyms: |
Igs2em1(pHsp68-Nfatc1-CreERT2) |
| Gene: |
Igs2 Location: Chr11:3195460-3195497 bp Genetic Position: Chr11, Syntenic
|
| Alliance: |
Igs2em6(Nfatc1-cre/ERT2)Cya page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Inducible, Recombinase) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Igs2em6(Nfatc1-cre/ERT2)Cya expression driven by
1 gene
Knock-in expression driven by:
| Organism |
Driver Gene |
Note |
| mouse |
Nfatc1 (MGI:102469) |
|
|
| |
|
Mutation details: H11-pHsp68-Nfatc1-CreERT2 allele was generated by knocking the Hsp68 minimal promoter-Kozak-CreERT2-WPRE-BGH pA-Mouse Nfatc1 enhancer cassette into the mouse H11 safe harbor locus via genome editing. Without tamoxifen treatment, CreERT2 recombinase primarily resides in the cytoplasm; nuclear translocation and recombination activity of CreERT2 only occur upon tamoxifen stimulation. When crossed with allele containing loxP sites, offspring are expected to undergo Cre-mediated recombination between loxP sites in Nfatc1-positive cells following tamoxifen administration.
(J:326541)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
Nfatc1
(mouse)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Igs2 Mutation: |
65 strains or lines available
|
|
|
|
Analysis Tools
